Published in AIDS Weekly, December 11th, 2006
Study 1: Data detailed in "Partner-specific sexual behavioral differences between phase 3 HIV vaccine efficacy trial participants and controls: Project VISION" have been presented. In this recently published article, scientists in the United States conducted a study "To assess and compare sexual behaviors using partner-specific data between HIV-negative men who have sex with men (MSM) recruited for an HIV vaccine efficacy trial and a control group. HIV-negative MSM from an HIV vaccine trial (n=525) and controls (n=732) were recruited by similar strategies and interviewed about...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of AIDS Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.